Updates

Get Alerts
With a free MyAccess profile, you can sign up to receive an email alert when new content is published on this site.
September 13, 2018 | Hematology-Oncology Therapy Updates General Update Thymic Malignancy Regimen: Octreotide ┬▒ Prednisone Hematology-Oncology Therapy
September 13, 2018 | Hematology-Oncology Therapy Updates General Update Thymic Malignancy Regimen: Sunitinib Hematology-Oncology Therapy
August 30, 2018 | Hematology-Oncology Therapy Updates General Update Metastatic Colorectal Cancer Regimen: Trifluridine/Tipiracil Hematology-Oncology Therapy
August 30, 2018 | Hematology-Oncology Therapy Updates General Update Metastatic Colorectal Cancer Regimen: Nivolumab Hematology-Oncology Therapy
August 30, 2018 | Hematology-Oncology Therapy Updates General Update Metastatic Colorectal Cancer Regimen: Pembrolizumab Hematology-Oncology Therapy
August 30, 2018 | Hematology-Oncology Therapy Updates General Update Adjuvant and Advanced Colorectal Cancer Regimen: Modified DE Gramont 5-Fluorouracil+Leucovorin┬▒Oxaliplatin Hematology-Oncology Therapy
August 30, 2018 | Hematology-Oncology Therapy Updates General Update Adjuvant Therapy Stage III Colon Cancer Regimen: mFOLFOX-6 Hematology-Oncology Therapy
August 30, 2018 | Hematology-Oncology Therapy Updates General Update Metastatic Colorectal Cancer Regimen: Folfoxiri + Bevacizumab Hematology-Oncology Therapy
August 30, 2018 | Hematology-Oncology Therapy Updates General Update Second-Line Metastatic Colorectal Cancer Regimen: Folfiri + Ramucirumab Hematology-Oncology Therapy
August 9, 2018 | Hematology-Oncology Therapy Updates General Update Pancreatic Neuroendocrine Tumor Regimen: Captem (Capecitabine + Temozolomide) Hematology-Oncology Therapy
August 9, 2018 | Hematology-Oncology Therapy Updates General Update Vaginal Cancer Regimen: Topotecan + Cisplatin (Topocis) Hematology-Oncology Therapy
July 26, 2018 | Hematology-Oncology Therapy Updates General Update NSCLC Second-Line Regimen: Atezolizumab Hematology-Oncology Therapy
July 26, 2018 | Hematology-Oncology Therapy Updates General Update NSCLC Second-Line Regimen: Pembrolizumab Hematology-Oncology Therapy
July 26, 2018 | Hematology-Oncology Therapy Updates General Update NSCLC Second-Line Regimen: Nivolumab Hematology-Oncology Therapy
July 26, 2018 | Hematology-Oncology Therapy Updates General Update NSCLC Second-Line Regimen: Ramucirumab + Docetaxel Hematology-Oncology Therapy
July 26, 2018 | Hematology-Oncology Therapy Updates General Update NSCLC with ALK Gene Rearrangement Regimen: Alectinib Hematology-Oncology Therapy
July 26, 2018 | Hematology-Oncology Therapy Updates General Update NSCLC with ALK Gene Rearrangement Regimen: Ceritinib Hematology-Oncology Therapy
June 23, 2017 | MD Anderson Manual of Oncology Updates General Update Chronic Myeloid Leukemia (Developments from ASCO June 2017) Elias Jabbour, MD
June 23, 2017 | MD Anderson Manual of Oncology Updates General Update Acute Lymphoblastic Leukemia (Developments from ASH December 2016) Elias Jabbour, MD
June 23, 2017 | MD Anderson Manual of Oncology Updates General Update Chronic Myeloid Leukemia (Developments from ASH December 2016) Elias Jabbour, MD
June 23, 2017 | MD Anderson Manual of Oncology Updates General Update Therapy for Indolent Lymphomas (Developments from ASH 2016 and ASCO 2017) Loretta Nastoupil, MD
January 23, 2017 | Williams Hematology Updates General Update Primary Myelofibrosis: Updated Diagnostic Criteria Marshal A. Lichtman, Josef T. Prchal
January 23, 2017 | Williams Hematology Updates General Update Cord-Blood Transplants in Patients with Acute Leukemia or Myelodysplastic Syndrome Linda Burns, MD
December 23, 2016 | Williams Hematology Updates General Update Specific Antidotes for Novel Oral Anticoagulants Evaluated Marcel Levi, MD, PhD
December 23, 2016 | Williams Hematology Updates General Update Treatment Advances in Hemophilia A and B Marcel Levi, MD, PhD